Meningeal 'Lazarus Response' to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

Autor: Francesco Facchinetti, Antonin Levy, Pernelle Lavaud, David Planchard, Samy Ammari, Benjamin Besse, C. Naltet, D. Vasseur, Mihaela Aldea

Publikováno v: Cancer Management and Research

Background ROS1 tyrosine kinase inhibitors (TKIs) have showed activity and efficacy in ROS1-rearranged non-small cell lung cancer (NSCLC). In the clinical practice, besides the utilization of crizotinib, less is known about the best treatment strateg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32656c78bea67504fce7adab008c319b
http://europepmc.org/articles/PMC8009349

Étude multicentrique cas témoins de l’efficacité en vie réelle de l’association chimiothérapie immunothérapie dans les cancers bronchiques à petites cellules disséminés

Autor: R. Ezzedine, J. Cadranel, C. Naltet, M. Wislez, R. Azarian, A. Seferian, E. Giroux Leprieur

Publikováno v: Revue des Maladies Respiratoires Actualités. 15:32

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7daea6d50d40dbaa958fe4e9274b1b85
https://doi.org/10.1016/j.rmra.2022.11.520

Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: findings from the SUMMIT basket trial

Autor: J. Goldman, A. Martínez Bueno, C. Dooms, K. Jhaveri, M.J. de Miguel, S.A. Piha-Paul, N. Unni, A. Mahipal, J.M. Suga, C. Naltet, A. Zick, M. Antoñanzas Basa, J. Crown, Y.K. Chae, D. DiPrimeo, L.D. Eli, L. McCulloch, D. Mahalingam

Publikováno v: European Journal of Cancer. 174:S82

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef24409de41ddf3aad403794eca7c3c1
https://doi.org/10.1016/s0959-8049(22)01017-6

Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases

Autor: Ludovic Lacroix, Benjamin Besse, Michèle Beau-Faller, Pamela Biondani, Lizza E.L. Hendriks, Pernelle Lavaud, Julien Adam, Anas Gazzah, Charlotte Leduc, Jordi Remon, Emilie Le Rhun, Ronan Flippot, Caroline Caramella, C. Naltet, David Planchard, Radj Gervais, Cécile Le Péchoux, Laura Mezquita, Dingyu Xiao, Edouard Auclin

Publikováno v: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩
Journal of Thoracic Oncology, 14(8), 1400-1407. Elsevier Science
Journal of Thoracic Oncology, 2019, 14, pp.1400-1407. ⟨10.1016/j.jtho.2019.05.007⟩

Introduction: Leptomeningeal metastases (LMs) are associated with dismal prognosis in NSCLC. Optimal management remains unknown in patients with EGFR-mutated NSCLC after initial tyrosine kinase inhibitor (TKI) failure.Methods: We conducted a multicen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511ce6023917bed9c979e64c0a2db523
https://doi.org/10.1016/j.jtho.2019.05.007

Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review

Autor: C. Naltet, Benjamin Besse

Publikováno v: Transl Lung Cancer Res

This article is a review of the literature concerning efficacy and safety of immune checkpoint inhibitors (ICIs) in the elderly population. In the past decade, immunotherapy deeply changed the treatment paradigm of lung cancer in particular in advanc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0337cf660997305194e9f94262ca050d
https://europepmc.org/articles/PMC8264351/